2025-05-10
#reports #ARTNA
[Artesian Resources Corporation](https://eninvs.com/all.php?name=ARTNA) (Utilities — Regulated Water) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185645)
(2025-05-05, After Market Close):
- Revenue +4% YoY (vs +8.0% in previous quarter and historical rate +5.5%)
- EBITDA +12.5% YoY (vs 0.0% in previous quarter and historical rate -2.2%)
- EBITDA margin 34.6% increased compared to 32.0% same period last year
- Net Debt decreased by $6 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) -$0 bln (negative), 0.8% of market cap
- EV/EBITDA multiple is 13.3x compared to historical level (75th percentile) of 15x
- EV/Sales multiple is 4.9x
At the opening of the session the share price went up +1.5% vs S&P500 -0.8%
------------------------------------------------
2025-05-10
#reports #RPID
[Rapid Micro Biosystems, Inc.](https://eninvs.com/all.php?name=RPID) (Medical Devices) reported for 2025 q1
(2025-05-09, Before Market Open):
- Revenue +16.7% YoY (vs +33.3% in previous quarter and historical rate +13.8%)
- EBITDA margin -142.9% increased compared to -216.7% same period last year
- Net Debt increased by $9 mln over the past reporting period (6.7% of market cap)
- FCF (LTM) -$0 bln (negative), 20.0% of market cap
- EV/Sales multiple is 3.3x
At the opening of the session the share price went up +22.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #PAR
[PAR Technology Corporation](https://eninvs.com/all.php?name=PAR) (Restaurant software and hardware solutions provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185461)
(2025-05-09, Before Market Open):
- Revenue -1% YoY (vs -2.8% in previous quarter and historical rate +8.3%)
- EBITDA margin -7.7% increased compared to -18.1% same period last year
- Net Debt increased by $40 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 1.9% of market cap
- EV/Sales multiple is 7.1x
At the opening of the session the share price went down -3.1% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #OB
[Outbrain Inc.](https://eninvs.com/all.php?name=OB) (Internet Content and Information) reported for 2025 q1
(2025-05-09, Before Market Open):
- Revenue +31.8% YoY (vs -5.2% in previous quarter and historical rate -2.3%)
- EBITDA margin -14.0% decreased compared to -1.4% same period last year
- Net Debt increased by $645 mln over the past reporting period (375.1% of market cap)
- FCF (LTM) -$0.7 bln (negative), 392.0% of market cap
- EV/Sales multiple is 0.7x
At the opening of the session the share price went down -9.9% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #III
[Information Services Group](https://eninvs.com/all.php?name=III) (Information Technology Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185520)
(2025-05-08, After Market Close):
- Revenue -6.3% YoY (vs -12.1% in previous quarter and historical rate -4.4%)
- EBITDA margin 6.7% increased compared to -1.6% same period last year
- Net Debt increased by $42 mln over the past reporting period (18.5% of market cap)
- EV/EBITDA multiple is 17.9x compared to historical level (75th percentile) of 15.3x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +3.5% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #GOGO
[Gogo](https://eninvs.com/all.php?name=GOGO) (Telecom Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185456)
(2025-03-14, Before Market Open):
- Revenue -2.9% YoY (vs 0.0% in previous quarter and historical rate +4.8%)
- EBITDA -12.8% YoY (vs -83.3% in previous quarter and historical rate -16.8%)
- EBITDA margin 33.7% decreased compared to 37.5% same period last year
- Net Debt decreased by $31 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0.3 bln (negative), 22.5% of market cap
- EV/EBITDA multiple is 25.4x compared to historical level (75th percentile) of 15.8x
- EV/Sales multiple is 5.6x
At the opening of the session the share price went up +10.3% vs S&P500 +0.8%
------------------------------------------------
2025-05-10
#reports #DXYN
[The Dixie Group](https://eninvs.com/all.php?name=DXYN) (Textile Manufacturing) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185453)
(2025-05-09, Before Market Open):
- Revenue -3.1% YoY (vs -4.5% in previous quarter and historical rate -9.6%)
- EBITDA margin 1.6% has not changed compared to 1.5% same period last year
- Net Debt decreased by $3 mln over the past reporting period (32.0% of market cap)
- FCF (LTM) +$0 bln (positive), 85.3% of market cap
- EV/Sales multiple is 0.4x
------------------------------------------------
2025-05-10
#reports #DIBS
[1stdibs.Com, Inc.](https://eninvs.com/all.php?name=DIBS) (Internet Retail) reported for 2025 q1
(2025-05-09, Before Market Open):
- Revenue +4.5% YoY (vs +9.5% in previous quarter and historical rate -5.0%)
- EBITDA margin -26.1% decreased compared to -22.7% same period last year
- Net Debt increased by $2 mln over the past reporting period (2.1% of market cap)
- FCF (LTM) -$0 bln (negative), 29.0% of market cap
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -6.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #CVRX
[CVRx, Inc.](https://eninvs.com/all.php?name=CVRX) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185512)
(2025-05-08, After Market Close):
- Revenue +9.1% YoY (vs +36.4% in previous quarter and historical rate +58.6%)
- EBITDA margin -108.3% increased compared to -200.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -23.3% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #ANIP
[ANI Pharmaceuticals](https://eninvs.com/all.php?name=ANIP) ( Specialty pharmaceutical company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185450)
(2025-05-09, Before Market Open):
- Revenue +43.8% YoY (vs +44.7% in previous quarter and historical rate +46.4%)
- EBITDA +40% YoY (vs -18.2% in previous quarter and historical rate +39.4%)
- EBITDA margin 24.9% decreased compared to 25.5% same period last year
- Net Debt decreased by $6 mln over the past reporting period (0.5% of market cap)
- FCF (LTM) -$0.4 bln (negative), 32.7% of market cap
- EV/EBITDA multiple is 21.8x compared to historical level (75th percentile) of 26.6x
- EV/Sales multiple is 2.7x
At the opening of the session the share price went up +6.3% vs S&P500 +0.3%
------------------------------------------------
2025-05-10
#reports #ANIK
[Anika Therapeutics](https://eninvs.com/all.php?name=ANIK) (Pain medication manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185449)
(2025-03-12, After Market Close):
- Revenue -36.6% YoY (vs -27.9% in previous quarter and historical rate -2.2%)
- EBITDA margin -11.5% decreased compared to -7.3% same period last year
- Net Debt increased by $2 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 4.7% of market cap
- EV/Sales multiple is 1x
At the opening of the session the share price went down -4.1% vs S&P500 -0.1%
------------------------------------------------
2025-05-10
#reports #ROAD
[Construction Partners](https://eninvs.com/all.php?name=ROAD) (Engineering and Construction) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185445)
(2025-05-09, Before Market Open):
- Revenue +54.2% YoY (vs +41.6% in previous quarter and historical rate +27.8%)
- EBITDA +150% YoY (vs +18.4% in previous quarter and historical rate +59.0%)
- EBITDA margin 11.4% increased compared to 7.0% same period last year
- Net Debt increased by $183 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) -$0.7 bln (negative), 13.8% of market cap
- EV/EBITDA multiple is 23.7x compared to historical level (75th percentile) of 20.3x
- EV/Sales multiple is 3x
At the opening of the session the share price went up +4.9% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #YELP
[Yelp](https://eninvs.com/all.php?name=YELP) (Crowdsourcing platform) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +7.8% YoY (vs +5.8% in previous quarter and historical rate +10.2%)
- EBITDA +100% YoY (vs +140.0% in previous quarter and historical rate +60.4%)
- EBITDA margin 11.7% increased compared to 6.3% same period last year
- Net Debt decreased by $16 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 9.7x compared to historical level (75th percentile) of 21.2x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +11.6%
------------------------------------------------
2025-05-09
#reports #XRAY
[DENTSPLY SIRONA](https://eninvs.com/all.php?name=XRAY) (Dental materials and equipment manufacturer) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue -7.8% YoY (vs +83.6% in previous quarter and historical rate +4.1%)
- EBITDA +31.1% YoY (vs -509.4% in previous quarter and historical rate -36.3%)
- EBITDA margin 11.0% increased compared to 7.8% same period last year
- Net Debt increased by $22 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.2 bln (negative), 4.6% of market cap
- EV/Sales multiple is 1x
At the opening of the session the share price went up +8.0% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #XPOF
[Xponential Fitness, Inc.](https://eninvs.com/all.php?name=XPOF) (Leisure) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -3.7% YoY (vs -7.8% in previous quarter and historical rate +24.2%)
- EBITDA +8.3% YoY (vs -771.4% in previous quarter and historical rate +12.4%)
- EBITDA margin 16.9% increased compared to 15.0% same period last year
- Net Debt increased by $14 mln over the past reporting period (4.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 47.9% of market cap
- EV/Sales multiple is 8.1x
------------------------------------------------
2025-05-09
#reports #WWW
[Wolverine World Wide](https://eninvs.com/all.php?name=WWW) (Clothing/shoes/accessories manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185068)
(2025-05-08, Before Market Open):
- Revenue +4.3% YoY (vs -6.1% in previous quarter and historical rate -9.9%)
- EBITDA +550% YoY (vs +4500.0% in previous quarter and historical rate +34.8%)
- EBITDA margin 6.3% increased compared to 1.0% same period last year
- Net Debt increased by $109 mln over the past reporting period (8.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 6.4% of market cap
- EV/EBITDA multiple is 12.1x compared to historical level (75th percentile) of 13x
- EV/Sales multiple is 1.2x
At the opening of the session the share price went up +4.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #WRBY
[Warby Parker Inc.](https://eninvs.com/all.php?name=WRBY) (Medical Instruments and Supplies) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +12% YoY (vs +17.9% in previous quarter and historical rate +13.0%)
- EBITDA +200% YoY (vs +600.0% in previous quarter and historical rate +80.0%)
- EBITDA margin 6.7% increased compared to 2.5% same period last year
- Net Debt decreased by $12 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 0.1% of market cap
- EV/EBITDA multiple is 117.6x compared to historical level (75th percentile) of 402.3x
- EV/Sales multiple is 2.4x
At the opening of the session the share price went down -1.5% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #VTRS
[Viatris](https://eninvs.com/all.php?name=VTRS) (Medicines manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185063)
(2025-05-08, Before Market Open):
- Revenue -11.2% YoY (vs -8.1% in previous quarter and historical rate -6.7%)
- EBITDA -818.6% YoY (vs +323.1% in previous quarter and historical rate -21.2%)
- EBITDA margin -83.3% decreased compared to 10.3% same period last year
- Net Debt increased by $13.4 bln since the start of the year (121.8% of market cap)
- FCF (LTM) +$2.3 bln (positive), 20.9% of market cap
- EV/Sales multiple is 1.7x
At the opening of the session the share price went up +4.7% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #VREX
[Varex Imaging](https://eninvs.com/all.php?name=VREX) (Components for X-ray detectors manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185062)
(2025-05-08, After Market Close):
- Revenue +3.4% YoY (vs +5.3% in previous quarter and historical rate -0.7%)
- EBITDA +116.7% YoY (vs +50.0% in previous quarter and historical rate -4.4%)
- EBITDA margin 12.2% increased compared to 5.8% same period last year
- Net Debt decreased by $12 mln over the past reporting period (3.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 28.3% of market cap
- EV/EBITDA multiple is 8.1x compared to historical level (75th percentile) of 10.5x
- EV/Sales multiple is 0.9x
At the opening of the session the share price went down -4.0% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #VHI
[Valhi](https://eninvs.com/all.php?name=VHI) (Chemicals) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185061)
(2025-05-08, After Market Close):
- Revenue -9.8% YoY (vs +30.4% in previous quarter and historical rate -2.3%)
- EBITDA +35.7% YoY (vs +712.5% in previous quarter and historical rate +39.8%)
- EBITDA margin 11.6% increased compared to 7.7% same period last year
- Net Debt increased by $206 mln over the past reporting period (39.9% of market cap)
- FCF (LTM) -$0.3 bln (negative), 58.3% of market cap
- EV/EBITDA multiple is 3.4x compared to historical level (75th percentile) of 12.7x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -0.9% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #VERI
[Veritone](https://eninvs.com/all.php?name=VERI) (Software — Infrastructure) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -31.3% YoY (vs -35.3% in previous quarter and historical rate -2.0%)
- EBITDA margin -68.2% decreased compared to -43.8% same period last year
- EV/Sales multiple is 1.8x
At the opening of the session the share price went down -10.8% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #VCEL
[Vericel](https://eninvs.com/all.php?name=VCEL) (Medical services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185059)
(2025-05-08, Before Market Open):
- Revenue +3.9% YoY (vs +15.4% in previous quarter and historical rate +14.8%)
- EBITDA margin -18.9% decreased compared to -7.8% same period last year
- Net Debt increased by $3 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) -$0 bln (negative), 0.2% of market cap
- EV/EBITDA multiple is 509.2x compared to historical level (75th percentile) of 819.7x
- EV/Sales multiple is 8.5x
At the opening of the session the share price went down -0.5% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #UEIC
[Universal Electronics](https://eninvs.com/all.php?name=UEIC) ( Innovative products manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185057)
(2025-05-08, After Market Close):
- Revenue 0% YoY (vs +12.2% in previous quarter and historical rate -11.7%)
- Net Debt decreased by $7 mln over the past reporting period (8.8% of market cap)
- FCF (LTM) +$0 bln (positive), 23.8% of market cap
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +12.6% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TXG
[10X Genomics](https://eninvs.com/all.php?name=TXG) (Medical services provider) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +9.9% YoY (vs -10.3% in previous quarter and historical rate +8.4%)
- EBITDA margin -20.6% increased compared to -38.3% same period last year
- Net Debt decreased by $36 mln over the past reporting period (3.7% of market cap)
- FCF (LTM) +$0 bln (positive), 3.2% of market cap
- EV/Sales multiple is 1x
At the opening of the session the share price went up +9.0% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TTEK
[Tetra Tech](https://eninvs.com/all.php?name=TTEK) (Consulting company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185405)
(2025-05-07, After Market Close):
- Revenue +5.6% YoY (vs +15.7% in previous quarter and historical rate +24.7%)
- EBITDA -64.2% YoY (vs -66.9% in previous quarter and historical rate +3.9%)
- EBITDA margin 4.0% decreased compared to 11.8% same period last year
- Net Debt increased by $208 mln over the past reporting period (11.1% of market cap)
- FCF (LTM) +$0 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 7.2x compared to historical level (75th percentile) of 23.6x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +10.8% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #TTEC
[TTEC](https://eninvs.com/all.php?name=TTEC) (IT services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185055)
(2025-05-08, After Market Close):
- Revenue -7.5% YoY (vs -9.4% in previous quarter and historical rate -2.0%)
- EBITDA 0% YoY (vs -7.0% in previous quarter and historical rate -32.5%)
- EBITDA margin 8.8% increased compared to 8.1% same period last year
- Net Debt decreased by $18 mln over the past reporting period (9.5% of market cap)
- FCF (LTM) +$0 bln (positive), 5.8% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +17.8% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TSQ
[Townsquare Media](https://eninvs.com/all.php?name=TSQ) (Advertising Agencies) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue -1% YoY (vs +2.6% in previous quarter and historical rate +1.7%)
- EBITDA 0% YoY (vs +3000.0% in previous quarter and historical rate -4.6%)
- EBITDA margin 12.1% increased compared to 12.0% same period last year
- EV/EBITDA multiple is 13.2x compared to historical level (75th percentile) of 50.5x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +9.6% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #TPR
[Tapestry](https://eninvs.com/all.php?name=TPR) (Clothes seller) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185050)
(2025-05-08, Before Market Open):
- Revenue +7% YoY (vs -67.0% in previous quarter and historical rate +11.9%)
- EBITDA +20.1% YoY (vs -50.7% in previous quarter and historical rate +10.0%)
- EBITDA margin 18.5% increased compared to 16.5% same period last year
- Net Debt increased by $3.1 bln since the start of the year (16.3% of market cap)
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 8.3x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went up +5.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #TOST
[Toast, Inc.](https://eninvs.com/all.php?name=TOST) (Software — Infrastructure) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +24.4% YoY (vs +29.2% in previous quarter and historical rate +37.6%)
- EBITDA margin 6.4% increased compared to -2.4% same period last year
- Net Debt decreased by $74 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.5 bln (positive), 2.3% of market cap
- EV/EBITDA multiple is 71.5x compared to historical level (75th percentile) of 398.5x
- EV/Sales multiple is 3.5x
------------------------------------------------
2025-05-09
#reports #TMDX
[TransMedics Group](https://eninvs.com/all.php?name=TMDX) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185049)
(2025-05-08, After Market Close):
- Revenue +48.5% YoY (vs +50.6% in previous quarter and historical rate +133.5%)
- EBITDA +750% YoY (vs +466.7% in previous quarter and historical rate +100.0%)
- EBITDA margin 23.6% increased compared to 4.1% same period last year
- Net Debt increased by $26 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0 bln (negative), 1.4% of market cap
- EV/EBITDA multiple is 50.6x compared to historical level (75th percentile) of 70x
- EV/Sales multiple is 6.8x
At the opening of the session the share price went up +22.3% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TMCI
[Treace Medical Concepts, Inc.](https://eninvs.com/all.php?name=TMCI) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185048)
(2025-05-08, After Market Close):
- Revenue +3.9% YoY (vs +11.3% in previous quarter and historical rate +27.4%)
- EBITDA margin -24.5% increased compared to -33.3% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$0 bln (negative), 7.6% of market cap
- EV/Sales multiple is 1.9x
------------------------------------------------
2025-05-09
#reports #TKNO
[Alpha Teknova, Inc.](https://eninvs.com/all.php?name=TKNO) (Drug Manufacturers — Specialty and Generic) reported for 2025 q1
(2025-05-07, After Market Close):
- Revenue +11.1% YoY (vs +12.5% in previous quarter and historical rate +3.2%)
- EBITDA margin -40.0% increased compared to -77.8% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.7% of market cap)
- FCF (LTM) +$0 bln (positive), 5.6% of market cap
- EV/Sales multiple is 4.7x
At the opening of the session the share price went down -1.0% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #TGLS
[Tecnoglass](https://eninvs.com/all.php?name=TGLS) (Building Materials) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185046)
(2025-05-08, Before Market Open):
- Revenue +15% YoY (vs +23.1% in previous quarter and historical rate +23.2%)
- EBITDA +42.6% YoY (vs +29.8% in previous quarter and historical rate +52.8%)
- EBITDA margin 30.2% increased compared to 24.4% same period last year
- Net Debt decreased by $23 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0 bln (positive), 1.1% of market cap
- EV/EBITDA multiple is 13.9x compared to historical level (75th percentile) of 12.5x
- EV/Sales multiple is 4.1x
At the opening of the session the share price went up +6.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #TELA
[TELA Bio](https://eninvs.com/all.php?name=TELA) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185045)
(2025-05-08, After Market Close):
- Revenue +11.8% YoY (vs +5.9% in previous quarter and historical rate +35.2%)
- EBITDA margin -52.6% decreased compared to -29.4% same period last year
- Net Debt increased by $10 mln over the past reporting period (25.2% of market cap)
- FCF (LTM) +$0 bln (positive), 15.1% of market cap
- EV/Sales multiple is 0.5x
At the opening of the session the share price went up +8.0% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TCX
[Tucows](https://eninvs.com/all.php?name=TCX) (Domain name registrar) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185044)
(2025-05-08, After Market Close):
- Revenue +9.2% YoY (vs +6.9% in previous quarter and historical rate +5.6%)
- EBITDA margin 10.5% increased compared to -8.0% same period last year
- Net Debt increased by $25 mln over the past reporting period (13.4% of market cap)
- FCF (LTM) -$0.3 bln (negative), 175.4% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +1.5% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TBPH
[Theravance Biopharma](https://eninvs.com/all.php?name=TBPH) (Biotechnology) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue 0% YoY (vs +5.6% in previous quarter and historical rate +24.2%)
- EBITDA margin -93.3% decreased compared to -73.3% same period last year
- Net Debt decreased by $45 mln over the past reporting period (6.2% of market cap)
- FCF (LTM) -$0 bln (negative), 1.0% of market cap
- EV/Sales multiple is 9.8x
At the opening of the session the share price went down -6.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #TAP
[Molson Coors Beverage](https://eninvs.com/all.php?name=TAP) (Beer maker) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185042)
(2025-05-08, Before Market Open):
- Revenue -11.8% YoY (vs -2.7% in previous quarter and historical rate +8.6%)
- EBITDA -24% YoY (vs +70.2% in previous quarter and historical rate +21.1%)
- EBITDA margin 13.6% decreased compared to 15.8% same period last year
- Net Debt increased by $650 mln over the past reporting period (5.5% of market cap)
- FCF (LTM) -$0.2 bln (negative), 1.6% of market cap
- EV/EBITDA multiple is 7.6x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 1.3x
At the opening of the session the share price went down -7.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #SKIN
[The Beauty Health Company](https://eninvs.com/all.php?name=SKIN) (Special purpose acquisition company) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -13.6% YoY (vs -13.4% in previous quarter and historical rate +6.1%)
- EBITDA +11.9% YoY (vs -1300.0% in previous quarter and historical rate +0.4%)
- EBITDA margin 67.1% increased compared to 51.9% same period last year
- Net Debt decreased by $4 mln over the past reporting period (2.6% of market cap)
- FCF (LTM) +$0 bln (positive), 31.8% of market cap
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +22.2% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #SGHT
[Sight Sciences, Inc.](https://eninvs.com/all.php?name=SGHT) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185034)
(2025-05-08, After Market Close):
- Revenue -5.3% YoY (vs 0.0% in previous quarter and historical rate +26.7%)
- EBITDA margin -77.8% decreased compared to -73.7% same period last year
- Net Debt increased by $12 mln over the past reporting period (8.3% of market cap)
- FCF (LTM) -$0 bln (negative), 15.2% of market cap
- EV/Sales multiple is 1x
------------------------------------------------
2025-05-09
#reports #SG
[Sweetgreen, Inc.](https://eninvs.com/all.php?name=SG) (Restaurants) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +5.1% YoY (vs +228.8% in previous quarter and historical rate +49.0%)
- EBITDA margin -6.6% decreased compared to -6.3% same period last year
- Net Debt increased by $30 mln over the past reporting period (1.5% of market cap)
- FCF (LTM) -$0.1 bln (negative), 4.2% of market cap
- EV/Sales multiple is 1.8x
------------------------------------------------
2025-05-09
#reports #SENS
[Senseonics](https://eninvs.com/all.php?name=SENS) (Diagnostics and Research) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185032)
(2025-05-08, After Market Close):
- Revenue +20% YoY (vs 0.0% in previous quarter and historical rate +24.9%)
- EBITDA margin -216.7% increased compared to -360.0% same period last year
- Net Debt decreased by $48 mln over the past reporting period (10.3% of market cap)
- FCF (LTM) +$0 bln (positive), 3.2% of market cap
- EV/Sales multiple is 19.1x
At the opening of the session the share price went down -9.6% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #SCSC
[ScanSource](https://eninvs.com/all.php?name=SCSC) (Scanner supplier) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue -6.4% YoY (vs -15.6% in previous quarter and historical rate +8.5%)
- EBITDA -12% YoY (vs -20.6% in previous quarter and historical rate +0.8%)
- EBITDA margin 3.1% decreased compared to 3.3% same period last year
- Net Debt decreased by $37 mln over the past reporting period (4.0% of market cap)
- FCF (LTM) -$0 bln (negative), 2.2% of market cap
- EV/EBITDA multiple is 8.8x compared to historical level (75th percentile) of 7.7x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went up +2.3% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #RNG
[RingCentral](https://eninvs.com/all.php?name=RNG) (Software provider) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +4.8% YoY (vs +7.7% in previous quarter and historical rate +12.7%)
- EBITDA +130.4% YoY (vs +792.9% in previous quarter and historical rate +144.2%)
- EBITDA margin 17.3% increased compared to 7.9% same period last year
- Net Debt decreased by $85 mln over the past reporting period (3.3% of market cap)
- FCF (LTM) +$0.2 bln (positive), 7.1% of market cap
- EV/EBITDA multiple is 12.2x compared to historical level (75th percentile) of 62.4x
- EV/Sales multiple is 1.6x
At the opening of the session the share price went up +5.8% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #RKDA
[Arcadia Biosciences](https://eninvs.com/all.php?name=RKDA) (Agricultural Inputs) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185197)
(2023-08-10, After Market Close):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate -0.7%)
- EBITDA margin 100.0% increased compared to -300.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (38.9% of market cap)
- FCF (LTM) -$0 bln (negative), 116.7% of market cap
- EV/Sales multiple is -0.5x
At the opening of the session the share price went up +4.5%
------------------------------------------------
2025-05-09
#reports #PZZA
[Papa Johns International](https://eninvs.com/all.php?name=PZZA) (Owner of restaurants) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185026)
(2025-05-08, Before Market Open):
- Revenue +0.8% YoY (vs -75.1% in previous quarter and historical rate +9.8%)
- EBITDA -17.6% YoY (vs -77.7% in previous quarter and historical rate +22.6%)
- EBITDA margin 8.1% decreased compared to 9.9% same period last year
- Net Debt increased by $7 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0 bln (negative), 0.3% of market cap
- EV/EBITDA multiple is 10.2x compared to historical level (75th percentile) of 19x
- EV/Sales multiple is 1.1x
At the opening of the session the share price went up +5.7% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #PUBM
[PubMatic, Inc.](https://eninvs.com/all.php?name=PUBM) (Software — Application) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -4.5% YoY (vs +1.2% in previous quarter and historical rate +7.2%)
- EBITDA -100% YoY (vs -7.7% in previous quarter and historical rate +4.1%)
- Net Debt decreased by $4 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) -$0.1 bln (negative), 9.7% of market cap
- EV/EBITDA multiple is 6x compared to historical level (75th percentile) of 11.4x
- EV/Sales multiple is 1.5x
------------------------------------------------
2025-05-09
#reports #PTON
[Peloton Interactive](https://eninvs.com/all.php?name=PTON) (Recreational facilities manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185023)
(2025-05-08, Before Market Open):
- Revenue -13.1% YoY (vs +355.4% in previous quarter and historical rate -1.0%)
- EBITDA +55.6% YoY (vs -2400.0% in previous quarter and historical rate +38.0%)
- EBITDA margin 51.1% increased compared to 28.6% same period last year
- Net Debt decreased by $120 mln over the past reporting period (4.8% of market cap)
- FCF (LTM) +$0.3 bln (positive), 12.7% of market cap
- EV/EBITDA multiple is 11.8x compared to historical level (75th percentile) of 21.6x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -9.7% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #PRVA
[Privia Health Group, Inc.](https://eninvs.com/all.php?name=PRVA) (Health Information Services) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +15.7% YoY (vs +4.5% in previous quarter and historical rate +20.1%)
- EBITDA +133.3% YoY (vs +200.0% in previous quarter and historical rate +88.6%)
- EBITDA margin 1.5% increased compared to 0.7% same period last year
- Net Debt increased by $23 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.9% of market cap
- EV/EBITDA multiple is 83.8x compared to historical level (75th percentile) of 125.6x
- EV/Sales multiple is 1.4x
At the opening of the session the share price went up +5.1% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #POST
[Post](https://eninvs.com/all.php?name=POST) (Consumer packaged goods provider) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -2.4% YoY (vs +0.5% in previous quarter and historical rate +8.3%)
- EBITDA -4.2% YoY (vs +1.5% in previous quarter and historical rate +13.7%)
- EBITDA margin 39.8% decreased compared to 40.6% same period last year
- Net Debt increased by $199 mln over the past reporting period (3.1% of market cap)
- FCF (LTM) +$0.1 bln (positive), 1.6% of market cap
- EV/EBITDA multiple is 10.4x compared to historical level (75th percentile) of 10.9x
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -1.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #PODD
[Insulet](https://eninvs.com/all.php?name=PODD) (Medical equipment manufacturer) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +28.7% YoY (vs +17.3% in previous quarter and historical rate +24.5%)
- EBITDA +47.8% YoY (vs +2.5% in previous quarter and historical rate +47.3%)
- EBITDA margin 17.4% increased compared to 15.2% same period last year
- Net Debt decreased by $15 mln over the past reporting period (0.1% of market cap)
- FCF (LTM) +$0.2 bln (positive), 1.3% of market cap
- EV/EBITDA multiple is 54.2x compared to historical level (75th percentile) of 124.4x
- EV/Sales multiple is 8.4x
At the opening of the session the share price went up +18.0% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #PLTK
[Playtika Holding Corp.](https://eninvs.com/all.php?name=PLTK) (Electronic Gaming and Multimedia) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +8.4% YoY (vs +1.9% in previous quarter and historical rate -0.2%)
- EBITDA -22.4% YoY (vs -54.2% in previous quarter and historical rate -10.9%)
- EBITDA margin 14.7% decreased compared to 20.6% same period last year
- Net Debt increased by $76 mln over the past reporting period (3.8% of market cap)
- FCF (LTM) -$0.4 bln (negative), 21.5% of market cap
- EV/EBITDA multiple is 9.1x compared to historical level (75th percentile) of 9.6x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went down -8.7% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #PLNT
[Planet Fitness](https://eninvs.com/all.php?name=PLNT) ( Fitness centers owner) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +11.7% YoY (vs +19.3% in previous quarter and historical rate +24.1%)
- EBITDA +11.4% YoY (vs +17.1% in previous quarter and historical rate +55.0%)
- EBITDA margin 42.2% decreased compared to 42.3% same period last year
- Net Debt decreased by $50 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) -$0.1 bln (negative), 1.0% of market cap
- EV/EBITDA multiple is 19.8x compared to historical level (75th percentile) of 28.2x
- EV/Sales multiple is 8.3x
At the opening of the session the share price went down -1.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #PINS
[Pinterest](https://eninvs.com/all.php?name=PINS) (Online platform) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +15.5% YoY (vs +17.6% in previous quarter and historical rate +12.4%)
- EBITDA margin -3.5% increased compared to -6.8% same period last year
- Net Debt decreased by $109 mln over the past reporting period (0.6% of market cap)
- FCF (LTM) +$0.3 bln (positive), 1.8% of market cap
- EV/EBITDA multiple is 85.2x compared to historical level (75th percentile) of 162.2x
- EV/Sales multiple is 4.3x
At the opening of the session the share price went up +10.6% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #PDFS
[PDF Solutions](https://eninvs.com/all.php?name=PDFS) (Software — Application) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185015)
(2025-05-08, After Market Close):
- Revenue +17.1% YoY (vs +22.0% in previous quarter and historical rate +16.5%)
- EBITDA margin -4.2% decreased compared to -2.4% same period last year
- Net Debt increased by $129 mln over the past reporting period (17.0% of market cap)
- FCF (LTM) -$0.1 bln (negative), 17.9% of market cap
- EV/Sales multiple is 4.2x
At the opening of the session the share price went down -9.6% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #PCRX
[Pacira BioSciences](https://eninvs.com/all.php?name=PCRX) (Medicines manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185014)
(2025-05-08, After Market Close):
- Revenue +1.2% YoY (vs +3.3% in previous quarter and historical rate +7.1%)
- EBITDA -34.4% YoY (vs -26.5% in previous quarter and historical rate -11.6%)
- EBITDA margin 12.4% decreased compared to 19.2% same period last year
- Net Debt decreased by $9 mln over the past reporting period (0.8% of market cap)
- FCF (LTM) +$0 bln (positive), 3.1% of market cap
- EV/Sales multiple is 2.1x
At the opening of the session the share price went down -7.2% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #PBH
[Prestige Consumer Healthcare](https://eninvs.com/all.php?name=PBH) (Medicines manufacturer) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +7.2% YoY (vs +2.5% in previous quarter and historical rate +1.6%)
- EBITDA +6.7% YoY (vs +5.3% in previous quarter and historical rate +0.8%)
- EBITDA margin 32.3% decreased compared to 32.5% same period last year
- Net Debt decreased by $29 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 3.3% of market cap
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 462.6x
- EV/Sales multiple is 4.6x
At the opening of the session the share price went up +3.0% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #ORGO
[Organogenesis](https://eninvs.com/all.php?name=ORGO) (Drug Manufacturers — Specialty and Generic) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185012)
(2025-05-08, After Market Close):
- Revenue -20.9% YoY (vs +27.0% in previous quarter and historical rate +0.1%)
- EBITDA margin -26.4% decreased compared to -0.9% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) -$0.5 bln (negative), 70.7% of market cap
- EV/Sales multiple is 2.7x
At the opening of the session the share price went down -33.2% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #OMI
[Owens & Minor](https://eninvs.com/all.php?name=OMI) (Logistic services provider) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185011)
(2025-05-08, Before Market Open):
- Revenue +0.7% YoY (vs +1.5% in previous quarter and historical rate +2.8%)
- EBITDA -27.4% YoY (vs -250.4% in previous quarter and historical rate -9.3%)
- EBITDA margin 2.3% decreased compared to 3.2% same period last year
- Net Debt increased by $122 mln over the past reporting period (27.5% of market cap)
- FCF (LTM) -$0 bln (negative), 5.9% of market cap
- EV/EBITDA multiple is 78.5x compared to historical level (75th percentile) of 11.8x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +7.5% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #OLPX
[Olaplex Holdings, Inc.](https://eninvs.com/all.php?name=OLPX) (Specialty Retail) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue -2% YoY (vs -9.8% in previous quarter and historical rate -16.1%)
- EBITDA -50% YoY (vs -73.7% in previous quarter and historical rate -46.9%)
- EBITDA margin 11.3% decreased compared to 22.2% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 8.7% of market cap
- EV/EBITDA multiple is 14.8x compared to historical level (75th percentile) of 13.2x
- EV/Sales multiple is 2.3x
At the opening of the session the share price went up +0.8% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #OLO
[Olo Inc.](https://eninvs.com/all.php?name=OLO) (Software — Application) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +20.9% YoY (vs +20.6% in previous quarter and historical rate +24.4%)
- EBITDA margin 2.5% increased compared to -6.0% same period last year
- Net Debt increased by $2 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/Sales multiple is 3.3x
------------------------------------------------
2025-05-09
#reports #NXST
[Nexstar Media](https://eninvs.com/all.php?name=NXST) (Media company) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185008)
(2025-05-08, Before Market Open):
- Revenue -3.9% YoY (vs +14.1% in previous quarter and historical rate +4.6%)
- EBITDA -8.6% YoY (vs +45.0% in previous quarter and historical rate +6.7%)
- EBITDA margin 34.4% decreased compared to 36.2% same period last year
- Net Debt decreased by $104 mln over the past reporting period (1.6% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.9% of market cap
- EV/EBITDA multiple is 6.2x compared to historical level (75th percentile) of 7.7x
- EV/Sales multiple is 2.4x
At the opening of the session the share price went up +2.6% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #NTRA
[Natera](https://eninvs.com/all.php?name=NTRA) (Medical services provider) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +36.4% YoY (vs +53.1% in previous quarter and historical rate +40.8%)
- EBITDA margin -14.9% increased compared to -19.0% same period last year
- Net Debt decreased by $300 mln over the past reporting period (1.9% of market cap)
- FCF (LTM) +$0.1 bln (positive), 0.3% of market cap
- EV/Sales multiple is 8.3x
At the opening of the session the share price went down -0.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #NTCT
[NetScout Systems](https://eninvs.com/all.php?name=NTCT) (Software provider) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +1% YoY (vs +15.6% in previous quarter and historical rate -0.7%)
- EBITDA margin 21.5% increased compared to -6.4% same period last year
- Net Debt decreased by $139 mln over the past reporting period (9.0% of market cap)
- FCF (LTM) +$0 bln (positive), 0.7% of market cap
- EV/Sales multiple is 1.3x
At the opening of the session the share price went up +3.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #NSPR
[InspireMD](https://eninvs.com/all.php?name=NSPR) (Medical Devices) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184901)
(2025-05-09, Before Market Open):
- Revenue 0% YoY (vs 0.0% in previous quarter and historical rate +33.3%)
- EBITDA margin -550.0% decreased compared to -350.0% same period last year
- Net Debt increased by $9 mln over the past reporting period (44.2% of market cap)
- FCF (LTM) -$0 bln (negative), 44.2% of market cap
- EV/EBITDA multiple is 0.1x compared to historical level (75th percentile) of 1x
- EV/Sales multiple is -0.5x
At the opening of the session the share price went down -1.9% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #NKTR
[Nektar Therapeutics](https://eninvs.com/all.php?name=NKTR) (Medicines developer) reported for 2025 q1
(2025-03-12, After Market Close):
- Revenue -54.5% YoY (vs +20.8% in previous quarter and historical rate -5.7%)
- EBITDA -450% YoY (vs +1500.0% in previous quarter and historical rate +16.7%)
- EBITDA margin -70.0% decreased compared to 9.1% same period last year
- Net Debt increased by $35 mln over the past reporting period (27.0% of market cap)
- FCF (LTM) -$0 bln (negative), 16.9% of market cap
- EV/Sales multiple is 0.1x
At the opening of the session the share price went up +6.9% vs S&P500 -0.1%
------------------------------------------------
2025-05-09
#reports #MODV
[ModivCare](https://eninvs.com/all.php?name=MODV) (Health care provider) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -4.8% YoY (vs 0.0% in previous quarter and historical rate +9.8%)
- EBITDA -20.8% YoY (vs -26.2% in previous quarter and historical rate +1.3%)
- EBITDA margin 2.9% decreased compared to 3.5% same period last year
- Net Debt increased by $95 mln over the past reporting period (494.2% of market cap)
- FCF (LTM) -$0.1 bln (negative), 759.5% of market cap
- EV/EBITDA multiple is 108.4x compared to historical level (75th percentile) of 47.8x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -16.3% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #MNST
[Monster Beverage](https://eninvs.com/all.php?name=MNST) (Energy drink supplier) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -2.3% YoY (vs +4.7% in previous quarter and historical rate +8.8%)
- EBITDA +5% YoY (vs -11.8% in previous quarter and historical rate +4.6%)
- EBITDA margin 31.5% increased compared to 29.3% same period last year
- Net Debt increased by $411 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) -$1.4 bln (negative), 2.5% of market cap
- EV/EBITDA multiple is 27.8x compared to historical level (75th percentile) of 28.1x
- EV/Sales multiple is 7.6x
At the opening of the session the share price went down -0.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #MNKD
[MannKind Corporation](https://eninvs.com/all.php?name=MNKD) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185003)
(2025-05-08, Before Market Open):
- Revenue +18.2% YoY (vs +32.8% in previous quarter and historical rate +73.3%)
- EBITDA +33.3% YoY (vs +190.0% in previous quarter and historical rate +115.3%)
- EBITDA margin 30.8% increased compared to 27.3% same period last year
- Net Debt increased by $16 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 8.6% of market cap
- EV/EBITDA multiple is 12.4x compared to historical level (75th percentile) of 38.4x
- EV/Sales multiple is 3.5x
At the opening of the session the share price went down -4.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #MG
[Mistras Group](https://eninvs.com/all.php?name=MG) (Security and Protection Services) reported for 2025 q1
(2025-05-05, After Market Close):
- Revenue -12% YoY (vs -4.9% in previous quarter and historical rate +1.2%)
- EBITDA -63.6% YoY (vs +142.9% in previous quarter and historical rate +30.1%)
- EBITDA margin 2.5% decreased compared to 6.0% same period last year
- Net Debt increased by $3 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 1.2% of market cap
- EV/EBITDA multiple is 6.5x compared to historical level (75th percentile) of 17.8x
- EV/Sales multiple is 0.6x
At the opening of the session the share price went down -1.2% vs S&P500 -0.8%
------------------------------------------------
2025-05-09
#reports #MCK
[McKesson](https://eninvs.com/all.php?name=MCK) (Pharmaceuticals and medical products supplier) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +18.9% YoY (vs +17.8% in previous quarter and historical rate +10.9%)
- EBITDA +27.2% YoY (vs +73.0% in previous quarter and historical rate +32.3%)
- EBITDA margin 1.9% increased compared to 1.8% same period last year
- Net Debt decreased by $6.9 bln since the start of the year (7.0% of market cap)
- FCF (LTM) -$5.8 bln (negative), 5.8% of market cap
- EV/EBITDA multiple is 20.8x compared to historical level (75th percentile) of 19.4x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went up +3.2% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #MCHP
[Microchip Technology](https://eninvs.com/all.php?name=MCHP) (Semiconductor products manufacturer) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -26.8% YoY (vs -41.9% in previous quarter and historical rate -8.5%)
- EBITDA -66.5% YoY (vs -64.3% in previous quarter and historical rate -12.4%)
- EBITDA margin 18.3% decreased compared to 40.1% same period last year
- Net Debt decreased by $1.3 bln since the start of the year (4.8% of market cap)
- FCF (LTM) -$0.5 bln (negative), 1.8% of market cap
- EV/EBITDA multiple is 29.3x compared to historical level (75th percentile) of 16.7x
- EV/Sales multiple is 7.3x
At the opening of the session the share price went up +17.9% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #MBUU
[Malibu Boats](https://eninvs.com/all.php?name=MBUU) (Sport boats manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185000)
(2025-05-08, Before Market Open):
- Revenue +12.8% YoY (vs -5.2% in previous quarter and historical rate -7.6%)
- EBITDA margin 8.3% increased compared to -36.0% same period last year
- Net Debt increased by $1 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) -$0 bln (negative), 3.3% of market cap
- EV/Sales multiple is 0.8x
At the opening of the session the share price went down -1.2% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #LTRX
[Lantronix](https://eninvs.com/all.php?name=LTRX) (Communication Equipment) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -29.3% YoY (vs -16.2% in previous quarter and historical rate +23.4%)
- Net Debt decreased by $2 mln over the past reporting period (2.5% of market cap)
- FCF (LTM) -$0 bln (negative), 7.6% of market cap
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -5.3% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #LTH
[Life Time Group Holdings, Inc.](https://eninvs.com/all.php?name=LTH) (Leisure) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +18.3% YoY (vs +18.6% in previous quarter and historical rate +21.8%)
- EBITDA +29.7% YoY (vs +27.6% in previous quarter and historical rate +104.7%)
- EBITDA margin 25.4% increased compared to 23.1% same period last year
- Net Debt decreased by $22 mln over the past reporting period (0.3% of market cap)
- FCF (LTM) +$0.4 bln (positive), 5.5% of market cap
- EV/EBITDA multiple is 15.3x compared to historical level (75th percentile) of 20.3x
- EV/Sales multiple is 3.8x
At the opening of the session the share price went up +4.0% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #LNG
[Cheniere Energy](https://eninvs.com/all.php?name=LNG) (Oil and Gas Midstream) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +28% YoY (vs -8.0% in previous quarter and historical rate +14.8%)
- EBITDA +211.3% YoY (vs -25.3% in previous quarter and historical rate +70.0%)
- EBITDA margin 83.2% increased compared to 34.2% same period last year
- Net Debt increased by $647 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) +$2.4 bln (positive), 4.0% of market cap
- EV/EBITDA multiple is 8.5x compared to historical level (75th percentile) of 10.7x
- EV/Sales multiple is 5.3x
At the opening of the session the share price went down -1.1% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #LMAT
[LeMaitre Vascular](https://eninvs.com/all.php?name=LMAT) (Medical equipment manufacturer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185129)
(2025-02-27, After Market Close):
- Revenue +13.2% YoY (vs +14.3% in previous quarter and historical rate +12.8%)
- EBITDA +7.1% YoY (vs +15.4% in previous quarter and historical rate +15.7%)
- EBITDA margin 25.0% decreased compared to 26.4% same period last year
- Net Debt decreased by $3 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0 bln (positive), 1.5% of market cap
- EV/EBITDA multiple is 27.2x compared to historical level (75th percentile) of 34.4x
- EV/Sales multiple is 7.5x
At the opening of the session the share price went down -9.9% vs S&P500 -0.3%
------------------------------------------------
2025-05-09
#reports #LGND
[Ligand Pharmaceuticals](https://eninvs.com/all.php?name=LGND) (Medicines manufacturer) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +45.2% YoY (vs +53.6% in previous quarter and historical rate -2.2%)
- EBITDA -325% YoY (vs -75.0% in previous quarter and historical rate -31.2%)
- EBITDA margin -60.0% decreased compared to 38.7% same period last year
- Net Debt increased by $38 mln over the past reporting period (2.2% of market cap)
- FCF (LTM) -$0 bln (negative), 2.5% of market cap
- EV/Sales multiple is 8.3x
At the opening of the session the share price went up +1.2% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #LCUT
[Lifetime Brands](https://eninvs.com/all.php?name=LCUT) (Furnishings, Fixtures and Appliances) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue -1.4% YoY (vs +5.9% in previous quarter and historical rate -6.9%)
- EBITDA 0% YoY (vs +14.3% in previous quarter and historical rate +33.0%)
- EBITDA margin 5.0% has not changed compared to 4.9% same period last year
- Net Debt decreased by $15 mln over the past reporting period (23.2% of market cap)
- FCF (LTM) +$0 bln (positive), 40.2% of market cap
- EV/EBITDA multiple is 5.5x compared to historical level (75th percentile) of 22.8x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -3.0% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #LASR
[nLight](https://eninvs.com/all.php?name=LASR) (Semiconductor laser products manufacturer) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue +15.6% YoY (vs -9.6% in previous quarter and historical rate -8.4%)
- EBITDA margin -11.5% increased compared to -22.2% same period last year
- Net Debt increased by $5 mln over the past reporting period (1.2% of market cap)
- FCF (LTM) -$0 bln (negative), 5.5% of market cap
- EV/Sales multiple is 1.6x
------------------------------------------------
2025-05-09
#reports #KLXE
[KLX Energy Services](https://eninvs.com/all.php?name=KLXE) (Oil and Gas Equipment and Services) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -12% YoY (vs -14.4% in previous quarter and historical rate +21.7%)
- EBITDA -22.2% YoY (vs -9.1% in previous quarter and historical rate +55.6%)
- EBITDA margin 4.5% decreased compared to 5.1% same period last year
- Net Debt increased by $46 mln over the past reporting period (168.9% of market cap)
- FCF (LTM) +$0 bln (positive), 102.8% of market cap
- EV/EBITDA multiple is 4.3x compared to historical level (75th percentile) of 4.2x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -13.0% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #KLTR
[Kaltura, Inc.](https://eninvs.com/all.php?name=KLTR) (Software — Infrastructure) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +4.4% YoY (vs +4.5% in previous quarter and historical rate +2.1%)
- EBITDA -45.5% YoY (vs -38.5% in previous quarter and historical rate +50.5%)
- EBITDA margin 12.8% decreased compared to 24.4% same period last year
- Net Debt increased by $17 mln over the past reporting period (6.1% of market cap)
- FCF (LTM) +$0 bln (positive), 0.4% of market cap
- EV/EBITDA multiple is 7.3x compared to historical level (75th percentile) of 6.2x
- EV/Sales multiple is 1.5x
At the opening of the session the share price went up +3.2% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #KFS
[Kingsway Financial Services](https://eninvs.com/all.php?name=KFS) (Auto and Truck Dealerships) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=185101)
(2024-11-06, After Market Close):
- Revenue +7.7% YoY (vs +15.4% in previous quarter and historical rate +8.1%)
- EBITDA -50% YoY (vs +100.0% in previous quarter)
- EBITDA margin 3.6% decreased compared to 7.7% same period last year
- Net Debt increased by $12 mln over the past reporting period (5.0% of market cap)
- FCF (LTM) -$0 bln (negative), 9.9% of market cap
- EV/EBITDA multiple is 29.3x compared to historical level (75th percentile) of 355x
- EV/Sales multiple is 2.1x
------------------------------------------------
2025-05-09
#reports #INSM
[Insmed](https://eninvs.com/all.php?name=INSM) (Biotechnology) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184986)
(2025-05-08, Before Market Open):
- Revenue +22.4% YoY (vs +23.8% in previous quarter and historical rate +24.3%)
- EBITDA margin -265.6% decreased compared to -189.5% same period last year
- Net Debt increased by $229 mln over the past reporting period (2.1% of market cap)
- EV/Sales multiple is 28.2x
At the opening of the session the share price went down -0.6% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #INSG
[Inseego](https://eninvs.com/all.php?name=INSG) (Communication equipment developer) reported for 2025 q1
(2024-05-08, After Market Close):
- Revenue -28.9% YoY (vs -23.3% in previous quarter and historical rate -12.5%)
- EBITDA margin 6.3% increased compared to -2.2% same period last year
- Net Debt increased by $4 mln over the past reporting period (0.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 13.4% of market cap
- EV/EBITDA multiple is 63.5x compared to historical level (75th percentile) of 183.3x
- EV/Sales multiple is 5.7x
At the opening of the session the share price went up +0.3% vs S&P500 0.0%
------------------------------------------------
2025-05-09
#reports #ICUI
[ICU Medical](https://eninvs.com/all.php?name=ICUI) (Peripheral venous catheter producer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184982)
(2025-05-08, After Market Close):
- Revenue +6.7% YoY (vs +7.1% in previous quarter and historical rate +20.6%)
- EBITDA +37.8% YoY (vs +102.2% in previous quarter and historical rate +43.1%)
- EBITDA margin 10.2% increased compared to 7.9% same period last year
- Net Debt increased by $1.2 bln since the start of the year (35.8% of market cap)
- FCF (LTM) +$0.1 bln (positive), 2.4% of market cap
- EV/EBITDA multiple is 16.9x compared to historical level (75th percentile) of 29.1x
- EV/Sales multiple is 2x
------------------------------------------------
2025-05-09
#reports #HUBS
[HubSpot](https://eninvs.com/all.php?name=HUBS) (Platform for marketing and sales) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184981)
(2025-05-08, After Market Close):
- Revenue +15.7% YoY (vs +20.8% in previous quarter and historical rate +24.6%)
- EBITDA margin -1.7% decreased compared to -1.3% same period last year
- Net Debt decreased by $64 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.6 bln (positive), 1.8% of market cap
- EV/Sales multiple is 11.1x
At the opening of the session the share price went down -8.2% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #HUBG
[Hub](https://eninvs.com/all.php?name=HUBG) (Service transportation provider) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -8.4% YoY (vs -1.1% in previous quarter and historical rate -3.8%)
- EBITDA -6.7% YoY (vs -1.5% in previous quarter and historical rate +1.7%)
- EBITDA margin 7.7% increased compared to 7.5% same period last year
- Net Debt decreased by $21 mln over the past reporting period (1.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.0% of market cap
- EV/EBITDA multiple is 9.3x compared to historical level (75th percentile) of 10.2x
- EV/Sales multiple is 0.7x
------------------------------------------------
2025-05-09
#reports #HQI
[HireQuest](https://eninvs.com/all.php?name=HQI) (Staffing and Employment Services) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184979)
(2025-05-08, After Market Close):
- Revenue -12.5% YoY (vs -20.0% in previous quarter and historical rate +5.4%)
- EBITDA -33.3% YoY (vs 0.0% in previous quarter and historical rate -7.0%)
- EBITDA margin 28.6% decreased compared to 37.5% same period last year
- Net Debt decreased by $2 mln over the past reporting period (1.4% of market cap)
- FCF (LTM) +$0 bln (positive), 8.5% of market cap
- EV/EBITDA multiple is 22.6x compared to historical level (75th percentile) of 16.8x
- EV/Sales multiple is 4.3x
At the opening of the session the share price went down -5.5% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #GTIM
[Good Times Restaurants](https://eninvs.com/all.php?name=GTIM) (Restaurants) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184976)
(2025-05-08, After Market Close):
- Revenue -2.9% YoY (vs +9.1% in previous quarter and historical rate +6.4%)
- EBITDA -33.3% YoY (vs 0.0% in previous quarter and historical rate -6.3%)
- EBITDA margin 5.9% decreased compared to 8.6% same period last year
- Net Debt decreased by $2 mln over the past reporting period (9.5% of market cap)
- FCF (LTM) +$0 bln (positive), 4.8% of market cap
- EV/EBITDA multiple is 12.6x compared to historical level (75th percentile) of 14.8x
- EV/Sales multiple is 0.4x
At the opening of the session the share price went down -4.8% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #GPRE
[Green Plains](https://eninvs.com/all.php?name=GPRE) (Specialty Chemicals) reported for 2025 q1
(2025-05-08, Before Market Open):
- Revenue +0.8% YoY (vs -18.0% in previous quarter and historical rate -4.6%)
- EBITDA margin -6.6% decreased compared to -3.9% same period last year
- Net Debt increased by $68 mln over the past reporting period (27.7% of market cap)
- FCF (LTM) -$0 bln (negative), 4.9% of market cap
- EV/EBITDA multiple is 15.6x compared to historical level (75th percentile) of 91.9x
- EV/Sales multiple is 0.3x
At the opening of the session the share price went down -0.3% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #GMED
[Globus Medical](https://eninvs.com/all.php?name=GMED) (Medical equipment developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184971)
(2025-05-08, After Market Close):
- Revenue -1.5% YoY (vs +6.5% in previous quarter and historical rate +44.6%)
- EBITDA +158.7% YoY (vs +59.3% in previous quarter and historical rate +53.6%)
- EBITDA margin 27.3% increased compared to 10.4% same period last year
- Net Debt decreased by $16 mln over the past reporting period (0.2% of market cap)
- FCF (LTM) +$0.7 bln (positive), 6.6% of market cap
- EV/EBITDA multiple is 14.3x compared to historical level (75th percentile) of 31.1x
- EV/Sales multiple is 3.8x
At the opening of the session the share price went down -20.6% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #GLP
[Global Partners LP](https://eninvs.com/all.php?name=GLP) (Oil and Gas Midstream) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184969)
(2025-05-08, Before Market Open):
- Revenue -23% YoY (vs -5.1% in previous quarter and historical rate +4.7%)
- EBITDA >1000% YoY (vs -55.4% in previous quarter and historical rate +36.3%)
- EBITDA margin 100.1% increased compared to 1.4% same period last year
- Net Debt increased by $125 mln over the past reporting period (7.7% of market cap)
- FCF (LTM) -$0.4 bln (negative), 22.0% of market cap
- EV/EBITDA multiple is 1x compared to historical level (75th percentile) of 9.7x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went up +2.6% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #FNKO
[Funko](https://eninvs.com/all.php?name=FNKO) (Vinyl figurine manufacturer) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -11.6% YoY (vs +1.0% in previous quarter and historical rate -2.3%)
- EBITDA margin -12.0% decreased compared to -6.9% same period last year
- Net Debt increased by $23 mln over the past reporting period (10.4% of market cap)
- FCF (LTM) +$0.1 bln (positive), 26.1% of market cap
- EV/EBITDA multiple is 3.1x compared to historical level (75th percentile) of 36.8x
- EV/Sales multiple is 0.5x
At the opening of the session the share price went down -9.4% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #FEMY
[Femasys Inc.](https://eninvs.com/all.php?name=FEMY) (Medical Instruments and Supplies) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184964)
(2025-05-08, Before Market Open):
- Revenue +25.8% YoY (vs +52.0% in previous quarter and historical rate +53.1%)
- EBITDA margin -1576.5% decreased compared to -1251.3% same period last year
- Net Debt decreased by $145 mln over the past reporting period (1067.3% of market cap)
- FCF (LTM) -$14.8 bln (negative), 109026.9% of market cap
- EV/Sales multiple is 1.4x
At the opening of the session the share price went down -0.9% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #FARM
[Farmer Bros](https://eninvs.com/all.php?name=FARM) (Packaged Foods) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184961)
(2025-05-08, After Market Close):
- Revenue -3.5% YoY (vs +1.1% in previous quarter and historical rate +10.2%)
- EBITDA -150% YoY (vs -42.9% in previous quarter)
- EBITDA margin -1.2% decreased compared to 2.4% same period last year
- Net Debt increased by $2 mln over the past reporting period (4.9% of market cap)
- EV/EBITDA multiple is 13.6x compared to historical level (75th percentile) of 21.3x
- EV/Sales multiple is 0.2x
At the opening of the session the share price went down -11.0% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #EVCM
[EverCommerce Inc.](https://eninvs.com/all.php?name=EVCM) (Software — Infrastructure) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -16.5% YoY (vs +3.6% in previous quarter and historical rate +8.7%)
- EBITDA +77.8% YoY (vs +23.1% in previous quarter and historical rate +41.0%)
- EBITDA margin 22.5% increased compared to 10.6% same period last year
- Net Debt decreased by $14 mln over the past reporting period (0.7% of market cap)
- FCF (LTM) +$0.1 bln (positive), 4.0% of market cap
- EV/EBITDA multiple is 18.2x compared to historical level (75th percentile) of 29.5x
- EV/Sales multiple is 3.4x
------------------------------------------------
2025-05-09
#reports #EVC
[Entravision Communications Corporation](https://eninvs.com/all.php?name=EVC) (Broadcasting) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184956)
(2025-05-08, After Market Close):
- Revenue -66.8% YoY (vs -66.6% in previous quarter and historical rate -4.4%)
- EBITDA margin -53.3% decreased compared to -17.7% same period last year
- Net Debt increased by $12 mln over the past reporting period (7.0% of market cap)
- FCF (LTM) +$0 bln (positive), 1.2% of market cap
- EV/Sales multiple is 0.9x
At the opening of the session the share price went up +2.1% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #EPAM
[EPAM Systems](https://eninvs.com/all.php?name=EPAM) (Software developer) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184955)
(2025-05-08, Before Market Open):
- Revenue +11.8% YoY (vs +7.9% in previous quarter and historical rate +6.3%)
- EBITDA -19.5% YoY (vs +11.6% in previous quarter and historical rate -0.1%)
- EBITDA margin 8.2% decreased compared to 11.4% same period last year
- Net Debt increased by $108 mln over the past reporting period (1.1% of market cap)
- FCF (LTM) -$0.7 bln (negative), 7.3% of market cap
- EV/EBITDA multiple is 15.2x compared to historical level (75th percentile) of 24.3x
- EV/Sales multiple is 1.9x
At the opening of the session the share price went up +12.4% vs S&P500 +0.6%
------------------------------------------------
2025-05-09
#reports #EB
[Eventbrite](https://eninvs.com/all.php?name=EB) (Software — Application) reported for 2025 q1
(2025-05-08, After Market Close):
- Revenue -14% YoY (vs -13.6% in previous quarter and historical rate +14.9%)
- EBITDA margin -8.1% decreased compared to -4.7% same period last year
- Net Debt decreased by $62 mln over the past reporting period (28.3% of market cap)
- FCF (LTM) -$0.1 bln (negative), 32.9% of market cap
- EV/Sales multiple is -0.1x
At the opening of the session the share price went up +14.2% vs S&P500 +0.3%
------------------------------------------------
2025-05-09
#reports #DV
[DoubleVerify Holdings, Inc.](https://eninvs.com/all.php?name=DV) (Software — Application) reported for [2025 q1](https://eninvs.com/press_release.php?source=sec&form_type=10&id=184953)
(2025-05-08, After Market Close):
- Revenue +17% YoY (vs +11.0% in previous quarter and historical rate +38.4%)
- EBITDA +5.6% YoY (vs +6.3% in previous quarter and historical rate +50.0%)
- EBITDA margin 11.5% decreased compared to 12.8% same period last year
- Net Debt decreased by $8 mln over the past reporting period (0.3% of market cap)
- EV/EBITDA multiple is 18.6x compared to historical level (75th percentile) of 49.5x
- EV/Sales multiple is 3.5x
